Loomis, Sayles & Company
GBT

Loomis, Sayles & Company’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Loomis, Sayles & Company’s Portfolio GBT Stock Details GBT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
2018
Q3 		$12.3M Sell
2018
Q2 		$14.8M Buy
2018
Q1 		$14.3M Sell
2017
Q4 		$14.2M Buy